Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Genistein and Doxorubicin Hydrochloride

Research Papers that Mention the Interaction

“ Genistein also shows synergistic behavior with well-known anticancer drugs, such as adriamycin , docetaxel, and tamoxifen, suggesting a potential role in combination therapy.”
Advances in nutrition  •  2015  |  View Paper
“Altogether this study highlights the potential role of … in targeting HSPG receptors and synergistic delivery of Dox … Gen as a promising strategy to effectively inhibit BAC progression and these findings could open a new window to deliver combinations of chemotherapeutic agents along with anti-angiogenic ligands using hybrid nanoparticles.”
Biomaterials science  •  2020  |  View Paper
“Consistent with previous reports, genistein combined with doxorubicin had a synergistic effect on MCF-7/Adr cells, and genistein reduced the chemoresistance of these cells.”
“ Genistein treatment increased the intracellular accumulation of doxorubicin but did not influence P-gp function.”
“The combination of genistein and doxorubicin significantly induced cell cycle arrest and apoptosis.”
“Therefore, our results demonstrated that genistein combined with doxorubicin had a synergistic effect on MCF-7/Adr cells, and the mechanisms likely involve an increase in the intracellular accumulation of doxorubicin and suppression of HER2/neu expression.”
Oncology reports  •  2014  |  View Paper
“Collectively, our results clearly suggest that genistein pretreatment inactivates NF-kappaB and may contribute to increased growth inhibition and apoptosis induced by cisplatin, docetaxel, and doxorubicin in prostate, breast, lung, and pancreatic cancer cells.”
Cancer research  •  2005  |  View Paper
“ Genistein enhanced cytotoxic effect of ADR at low doses less than IC50 against the human breast cancer cell.”
“These results suggest that genistein enhances necrotic-like cell death of the breast cancer cells through the inactivation of HER-2 receptor and Akt in combination with ADR.”
Research communications in molecular pathology and pharmacology  •  2003  |  View Paper
“Combinations of genistein or tyrphostin AG 1478 with cisplatin, doxorubicin , or etoposide enhanced the antiproliferative effects and induced programmed cell death in NCI-H596 cells, whereas no such additive effects were observed in NCI-H358 cells.”
Anticancer research  •  1999  |  View Paper
“The tyrosine kinase inhibitor genistein was a potent blocker of doxorubicin efflux in the PSN1/ADR cells but showed no activity in the H134 AD cells.”
British Journal of Cancer  •  1996  |  View Paper
“Although the amount of ADM was decreased in the nuclei of K562/TPA cells, it was significantly increased after incubation in the presence of genistein.”
International journal of cancer  •  1994  |  View Paper
“Three inhibitors of tyrosine kinases genistein , kaempferol, and quercetin) can inhibit the in vitro generation of ADR activity.”
Experimental cell research  •  1993  |  View Paper
“ Genistein enhanced the Nrf2 and HO-1 expression, which showed protection against oxidative insult induced by Dox.”
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer  •  2019  |  View Paper